Skip to content

ZABRUS

Active
Private limited company (pre-2019)founded 1991active for 35 yearsPapenaard 12, 9830 Sint-Martens-Latem, BelgiumKBO/BCE: BE 0444.250.892
Summary

ZABRUS has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €80,859 and a net result of €21,415. Equity is growing by about 13% per year across the filed financial years. Its solvency ranks better than 72% of 13,632 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
1 site
Size
€119,641total assets 2025
Equity
€80,859
Profit
€21,415
Turnover not published (micro format)
Financial health
98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts filed 13 days late
Why 98lowers riskLiquidity: current ratio 2.90, cash €53,991Founded in 1991Equity €80,859 (67.6% of total assets)Figures for financial year 2025 (filed 20-05-2026)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 82% of its sector peers (NACE 46, micro)
Financial strength · tick = 2024
Strong
Solvency 93+21
equity 67.6% of total assets
Liquidity 86+60
short-term debt 32.4% · cash 45.1%
Profitability 91+21
return on assets 17.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,883 companies, NACE 46, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.4%▲ +0.2 percentage points vs 04-2025 06-2025: 0.2%▼ -0.2 percentage points vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.4%▲ +0.2 percentage points vs 03-2026 05-2026: 0.6%▲ +0.2 percentage points vs 04-2026highest value 06-2026: < 0.1%▼ -0.6 percentage points vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €7,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.9, compared with 1.71 in 2024, above the usual 1.5; short-term debt: 32.4% and cash: 45.1% of total assets), and 32.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 73% on solvency, 86% on liquidity, 85% on profitability and 84% on growth.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Liquidity: current ratio 2.90, cash €53,991
NBB · annual accounts
lowers risk · Founded in 1991
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Equity €80,859 (67.6% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 20-05-2026)
NBB · annual accounts
raises risk · 2025 accounts filed 13 days late
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 13-05-2026, 13 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
13 days late
2024
15 days late
2023
5 days early
2022
12 days early
2021
2 days early
2020
2 days early
2019
22 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 2 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 28 April (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end26-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2019 to 2025net €21,415 ▲1,104%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Active since 1991founded 27-05-1991 35 years View
  • Total assets 20256 financial years filed €119,641 View

By topic

Financials

Financial year
2025
Total assets
€119,641
Profit
€21,415
Solvency
67.6%
Total assets▼ 6.1%
Net result
20192025
Go to Financials

Timeline

Events
36
Since
1994
Next accounts
by 30-04-2027
  1. 30-09-2024Back to profit
  2. 25-04-2024Annual accounts filed
  3. 30-09-2023Weakest financial year
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
27-05-1991
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Key facts about ZABRUS

What is the company number of ZABRUS?
0444.250.892. In Belgium the VAT number is the company number with BE in front: BE 0444.250.892.
Where is ZABRUS based?
The registered office is at Papenaard 12, 9830 Sint-Martens-Latem.Company details
What does ZABRUS do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of ZABRUS?
Private limited company (pre-2019) (BVBA).
When was ZABRUS founded?
On 27-05-1991.
Is ZABRUS still active?
Yes, ZABRUS is an active enterprise in the KBO register.
What is the turnover of ZABRUS?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is ZABRUS profitable?
In financial year 2025, ZABRUS made a profit of €21,415.
Where can I find the annual accounts of ZABRUS?
ZABRUS filed 33 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ZABRUS due?
By 30-04-2027, for financial year 2026.Timeline

Companies related to ZABRUS

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.